Skip to main content

Accelerate Diagnostics Inc. Announces $150 Million Convertible Notes Offering

Accelerate Diagnostics, Inc. today announced its intention to offer, subject to market conditions and other factors, $150.0 million aggregate principal amount of convertible senior notes due 2023.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.